RTI Health Solutions, Research Triangle Park, NC, USA.
Value Health. 2019 May;22(5):570-574. doi: 10.1016/j.jval.2018.11.013.
In this commentary, celebrating the 20th anniversary of the journal Value in Health, I present a brief overview and illustration of the evolution over the past 20 years of the methodological literature providing guidelines for multivariable and structural uncertainty analysis for cost-effectiveness estimates.
To illustrate the impact of the guidelines for uncertainty analyses, I show how the inclusion of multivariable and structural uncertainty analyses in cost-effectiveness analyses published in Value in Health changed over the past 20 years using publications from 1999/2000, 2007 and 2017.
The commentary is organized in three sections: past, focusing on the development and use of methods for multivariable uncertainty analysis; present, focusing on the growing awareness of the need for structural uncertainty analysis, suggested frameworks for structural uncertainty analysis and how it is currently implemented; and future, considering different methods for combining multivariable and structural uncertainty analyses over the next decades.
I conclude by suggesting how the continued evolution of uncertainty analyses in published studies and health technology assessment submissions can best take into account an important goal of cost-effectiveness analyses: to provide useful information to decision makers.
在这篇评论中,庆祝《Value in Health》杂志创刊 20 周年,我简要概述并举例说明了过去 20 年来,为成本效益估计提供多变量和结构不确定性分析指南的方法文献的演变。
为了说明不确定性分析指南的影响,我展示了在《Value in Health》上发表的成本效益分析中,如何通过纳入多变量和结构不确定性分析来改变过去 20 年的情况,使用了 1999/2000 年、2007 年和 2017 年的出版物。
该评论分为三个部分:过去,重点介绍多变量不确定性分析方法的发展和使用;现在,重点关注对结构不确定性分析的需求不断增加,建议的结构不确定性分析框架以及目前的实施情况;以及未来,考虑在未来几十年中结合多变量和结构不确定性分析的不同方法。
我最后提出了如何在已发表的研究和卫生技术评估提交中继续发展不确定性分析,以最好地考虑成本效益分析的一个重要目标:为决策者提供有用的信息。